March 2026: Eli Lilly announced topline results from the Phase 3 TRANSCEND-T2D-1 trial, reporting significant A1C reductions and weight loss in study subjects
Potential Research Applications: Growth hormone secretion and endocrine studies Muscle growth, recovery, and anti-aging research models Fat metabolism and body composition studies GH axis and pituitary function investigations For laboratory research only
Peak side effects occur not because 4mg is intolerable, but because your body hasnt yet adapted to the increased stimulation
Improper disposal poses risks to individuals and to the wider environment, particularly with respect to pharmaceutical contamination of water systems
While the exact mechanism remains debated, clinical observations suggest that B12 supplementation reduces nausea severity in a subset of users
The FDA will assess safety across the full trial database